vaayaa.com
Healthcare 1 min read

FDA Approves First Treatment for Chronic Hepatitis Delta Virus (HDV) Infection

May 23, 2026

Today, the U.S. Food and Drug Administration approved Hepcludex (bulevirtide-gmod) injection to treat chronic hepatitis delta virus (HDV) infection in adults without cirrhosis (advanced liver scarring) or with compensated cirrhosis.

Read full article on FDA Press Releases →

Source: FDA Press Releases — US Government, Public Domain

More in Healthcare

What Pennsylvania’s AI chatbot lawsuit teaches us about the psychology behind medical trust The Conversation Health · 2 min World Cup creates perfect conditions for infectious diseases to spread – here are the biggest threats health experts are watching for The Conversation Health · 2 min FDA Broadens Access to Over-the-Counter Naloxone Nasal Spray for Opioid Overdose FDA Press Releases · 1 min Summer between high school graduation and college is a critical time for preventing risky behaviors – here’s how parents can play a key role The Conversation Health · 2 min